Biderra
Pharma and laboratory706680-2026

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

Open official TED notice Similar notices

Buyer country

Germany

Publication date

13 October 2026

Biderra sector

Pharma and laboratory

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
793 days to indexed deadline

31 December 2028

Indexed data completeness
86%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33600000

Medical equipment, pharmaceuticals and personal care products

90-day market activity
445 related notices

106 buyers in Germany / Pharma and laboratory

Buyer activity
22 indexed notices

Published by this buyer in the last 90 days

Market context

How this notice compares with the current market

Biderra found 445 pharma and laboratory notices from Germany in its rolling 90-day index. 23% publish an estimated value and 53% include at least one indexed deadline. This notice is currently active according to the deadline fields available in the source feed.

Recent notices

445

Value disclosed

23%

Deadline coverage

53%

Related active opportunities

More pharma and laboratory notices from Germany

View the full market

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Alemania – Productos farmacéuticos – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

Dutch

Duitsland – Farmaceutische producten – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

Polish

Niemcy – Produkty farmaceutyczne – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

French

Allemagne – Produits pharmaceutiques – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

German

Deutschland – Arzneimittel – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

Italian

Germania – Prodotti farmaceutici – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

English

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Brinzolamid/Timolol (amtlicher ATC-Code: S01ED67)

What Biderra adds

For notice 706680-2026, Biderra has normalized the contracting authority country as Germany, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.